Prognostic significance of DNA quantification by flow cytometry in ovarian tumors

International Journal of Gynecology and Obstetrics

Volumn 88, Issue 3, 2005, Pages 286-291

  Kim, Y T ^a   Zhao, M ^a   Kim, S H ^a   Lee, C S ^a   Kim, J H ^a   Kim, J W ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

CA 125; DNA ploidy; Ovarian tumor; Prognostic factor; S phase fraction

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL FRACTIONATION; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS;

EID: 14144254110     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2004.12.010     Document Type: Article

References (24)

1. K. Sigurdsson, P. Alm, and B. Gullberg Prognostic factors in malignant epithelial ovarian tumors Gynecol. Oncol. 15 1983 370 380
2. O.P. Kallioniemi, R. Punnonen, J. Mattila, M. Lehtinen, and T. Koivula Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer Cancer 61 1988 334 339
3. G.J. Rustin, A.E. Nelstrop, M.K. Tuxen, and H.E. Lambert Defining progression of ovarian carcinoma during follow-up according to CA-125: a North Thames Ovary Group Study Ann. Oncol. 7 1996 361 364
4. M.E. Van der Burg, F.B. Lammes, W. van Putten, and G. Stoter Ovarian cancer: the prognostic value of the serum half-life of CA-125 during induction chemotherapy Gynecol. Oncol. 30 1988 307 312
5. A. Rosen, P. Sevelda, M. Klein, and A. Beck A CA-125 score as a prognostic index in patients with ovarian cancer Arch. Gynecol. Obstet. 247 1990 125 129
6. O. Mogensen Prognostic value of CA-125 in advanced ovarian cancer Gynecol. Oncol. 44 1992 207 212
7. B. Barlogie, B. Drewinko, and J. Schumann Cellular DNA content as a marker of neoplasia in man Am. J. Med. 69 1980 195 203
8. R.L. Garcia, and A.M. Gown Analysis of proliferative grade using anti PCNA/cyclin monoclonal antibodies in formalin fixed, paraffin embedded tissues, comparison with flow cytometric analysis Am. J. Pathol. 134 1989 733 739
9. M.L. Friedlander, D.W. Heldey, and C. Swanson Prediction of long-term survivals by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer J. Clin. Oncol. 6 1988 282 290
10. L.W. Rice, S.D. Mark, R.S. Berkowitz, B.A. Goff, and J.M. Lage Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma Obstet. Gynecol. 86 1995 379 385
11. J.S. Meyer, D.J. Gorsell, and S. Yim Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction(SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate Gynecol. Oncol. 81 2001 466 476
12. N.R. Rose, E.C.D. Marcrio, J.L. Fahey, H. Frendman, and G.M. Penn Manual of clinical laboratory immunology 5th ed. 1997 ASM 255 261
13. Annual Report of the Central Cancer Registry in Korea. Central Cancer Registry Center in Korea. Republic of Korea. Ministry of Health and Welfare; 2003.
14. B. Barlogie, M.N. Raber, and J. Schumann Flow cytometry in clinical cancer research Cancer Res. 43 1983 3982 3989
15. M.L. Friedlander, D.W. Hedley, I.W. Taylor, P. Russel, A.S. Coates, and M.H.N. Tatersall Influence of cellular DNA content on survival in advanced ovarian cancer Cancer 44 1984 397 400
16. P. Strang, U. Stendahl, and B. Sorbe Polyclonal cervical tumors detected by flow cytometry Anticancer Res. 6 1986 171 176
17. J. Hansson, B. Tribukalt, R. Lewensohn, and U. Ringborg Flow cytofluorometric analyses of metastases of human malignant melanomas Anal. Quant. Cytol. 4 1982 99 104
18. D.E. Merkel, and W.L. McGuire Ploidy, proliferative activity and prognosis: DNA flow cytometry of solid tumors Cancer 65 1990 1194 1205
19. D.W. Hedley, M.L. Friedlander, I.W. Taylor, C.A. Rugg, and E.A. Musgrove Method for analysis of cellular DNA content to paraffin embedded pathological material using flow cytometry J. Histochem. Cytochem. 31 1983 1333 1336
20. B. Schutte, M.M. Reyners, and F.T. Bosman Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin embedded tissue Cytometry 6 1958 26 30
21. R.A. Stephenson, H. Gay, W.R. Fair, and M.R. Melamed Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embedded tissue Cytometry 7 1986 41 44
22. A.B. Jacobsen, S.D. Fossa, and E. Thorud DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material APMIS 96 1988 25 29
23. A.D. Deitch, R.D.V. White, and B.R. Madewell False DNA aneuploidy in canine and human neoplasms Anticancer Res. 13 1993 2117 2118
24. G.B. Nyvang, O. Mogensen, P. Bichel, and A. Jakobsen Combined prognostic importance of CA-125, histopathologic grade and DNA index in advanced ovarian cancer Eur. J. Gynecol. Oncol. 21 2000 569 572